Optas LLC Acquires 431 Shares of Colgate-Palmolive (NYSE:CL)

Optas LLC increased its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 3.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,458 shares of the company’s stock after purchasing an additional 431 shares during the period. Optas LLC’s holdings in Colgate-Palmolive were worth $1,314,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the stock. D Orazio & Associates Inc. grew its position in shares of Colgate-Palmolive by 3.9% in the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after purchasing an additional 108 shares during the last quarter. Fiducient Advisors LLC boosted its stake in Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after purchasing an additional 110 shares during the period. Sequoia Financial Advisors LLC grew its holdings in Colgate-Palmolive by 0.6% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock valued at $2,117,000 after buying an additional 113 shares during the last quarter. Waldron Private Wealth LLC increased its position in Colgate-Palmolive by 2.1% in the 3rd quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock worth $585,000 after buying an additional 118 shares during the period. Finally, Lantz Financial LLC lifted its holdings in shares of Colgate-Palmolive by 0.6% during the fourth quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock worth $1,831,000 after buying an additional 122 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday. Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. JPMorgan Chase & Co. reduced their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday. Finally, Raymond James reiterated an “outperform” rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $101.16.

Check Out Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Price Performance

NYSE:CL opened at $87.05 on Tuesday. The firm has a market cap of $71.12 billion, a PE ratio of 24.73, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30. The company’s 50-day moving average price is $91.35 and its two-hundred day moving average price is $97.15.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company posted $0.87 EPS. On average, equities analysts anticipate that Colgate-Palmolive will post 3.74 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.